Analytical Data
-
Gene name
VGLUT1
- Application
-
Alternative Names
SLC17A7; BNPI; Solute Carrier Family 17 Member 7,Sodium-Dependent Inorganic Phosphate Cotransporter; Brain-specific Na(+)-dependent inorganic phosphate cotransporter
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q3TXX4
-
Expression Region
Ser491~Tyr560
-
Molecular Weight
30kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VGLUT1 (Vesicular Glutamate Transporter 1) plays a crucial role in the regulation of glutamate, the primary excitatory neurotransmitter in the central nervous system. By facilitating the packaging of glutamate into synaptic vesicles, VGLUT1 is essential for synaptic transmission and neuronal communication. Dysregulation of glutamate signaling is implicated in various neuropsychiatric disorders, such as schizophrenia, autism, and epilepsy, making VGLUT1 a significant focus of research. The study of VGLUT1 recombinant protein has emerged as a vital approach to deepen our understanding of its functional mechanisms, regulation, and interaction with other proteins. Utilizing recombinant DNA technology, researchers can produce VGLUT1 in controlled laboratory conditions, allowing for detailed analysis of its structural and functional properties. Additionally, understanding the molecular dynamics of VGLUT1 can provide insights into potential therapeutic strategies aimed at modulating glutamatergic signaling, ultimately contributing to the development of treatments for disorders associated with glutamate dysregulation. As research advances, the characterization of VGLUT1 recombinant protein continues to shed light on its significance in neuronal function and overall brain health, highlighting its potential as a target for pharmacological intervention.
